Steward Partners Investment Advisory’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Steward Partners Investment Advisory’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18	Buy	+1	New	+$23	﹤0.01%	4617
2022 Q3	–	Sell	-5	Closed	-$2K	–	3355
2022 Q2	$2K	Sell	5 -1	-17%	-$707	﹤0.01%	3035
2022 Q1	$7K	Buy	6 +3	+100%	+$4.08K	﹤0.01%	2788
2021 Q4	$6K	Hold	3	–	–	﹤0.01%	2781
2021 Q3	$46K	Hold	3	–	–	﹤0.01%	1949
2021 Q2	$27K	Hold	3	–	–	﹤0.01%	4453
2021 Q1	$18K	Hold	3	–	–	﹤0.01%	2524
2020 Q4	$14K	Buy	3 +2	+200%	+$17.7K	﹤0.01%	2188
2020 Q3	$12K	Sell	1 -1	-50%	-$9.1K	﹤0.01%	2074
2020 Q2	$22K	Buy	+2	New	+$18.3K	﹤0.01%	1739

Other funds holding IRLA

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Steward Partners Investment Advisory's IRLA Position: Q2 2026 in Review

Steward Partners Investment Advisory opened a new position in IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2026: 1 share worth $18. The stake represents ﹤0.01% of the portfolio and ranks #4617 among its holdings. This is a return to the name: Steward Partners Investment Advisory previously reported a position in IRLA as recently as Q2 2022.

Steward Partners Investment Advisory first reported a position in IRLA in Q2 2020 and has held it in 10 quarters since. The position peaked at $46K in Q3 2021. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

Steward Partners Investment Advisory held 1 share of IRulya Therapeutics Inc. Common Stock worth $18 as of Q2 2026.
IRulya Therapeutics Inc. Common Stock was a new Steward Partners Investment Advisory position in Q2 2026.
IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4617 holding.
Steward Partners Investment Advisory first reported a position in IRulya Therapeutics Inc. Common Stock in Q2 2020 and has held it in 10 quarters since.
Steward Partners Investment Advisory's IRulya Therapeutics Inc. Common Stock position peaked at $46K in Q3 2021.
26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.